MY01
QC - MontréalBiotechnology
Focus: MY01 is an early-stage medical device biotech focused on a continuous pressure monitoring sensor for acute compartment syndrome, a time-sensitive orthopedic emergency. The company operates at Series A stage with 51-200 employees from its Montréal headquarters.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
SERIES A
Employees
51-200
Total Funding
$50M
Open Jobs
0
About MY01
AI assessmentNot HiringNo open roles listed right now. Follow MY01 to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MY01 Continuous Compartmental Pressure Monitor
Compartment Syndrome Traumatic Lower ExtremityClinical Trials (1)
NCT04012723Clinical Trial of a New Device for Real-Time Muscle Pressure Measurements in Patients at Risk for Acute Compartment Syndrome
N/AHelp build intelligence for MY01
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.